WO2014150013A1 - Percutaneous transluminal angioplasty device with integral embolic filter - Google Patents

Percutaneous transluminal angioplasty device with integral embolic filter Download PDF

Info

Publication number
WO2014150013A1
WO2014150013A1 PCT/US2014/021850 US2014021850W WO2014150013A1 WO 2014150013 A1 WO2014150013 A1 WO 2014150013A1 US 2014021850 W US2014021850 W US 2014021850W WO 2014150013 A1 WO2014150013 A1 WO 2014150013A1
Authority
WO
WIPO (PCT)
Prior art keywords
ring
filter
catheter
scaffolding
distal
Prior art date
Application number
PCT/US2014/021850
Other languages
French (fr)
Inventor
Ravish Sachar
Udayan G. Patel
Original Assignee
Contego Medical, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/838,523 external-priority patent/US20170007390A9/en
Application filed by Contego Medical, Llc filed Critical Contego Medical, Llc
Priority to JP2016500864A priority Critical patent/JP2016511086A/en
Priority to CN201480025256.6A priority patent/CN105188605B/en
Priority to BR112015023627A priority patent/BR112015023627A8/en
Priority to EP14768559.8A priority patent/EP2967808A4/en
Priority to AU2014237626A priority patent/AU2014237626A1/en
Publication of WO2014150013A1 publication Critical patent/WO2014150013A1/en
Priority to HK16102513.6A priority patent/HK1214495A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/013Distal protection devices, i.e. devices placed distally in combination with another endovascular procedure, e.g. angioplasty or stenting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/016Filters implantable into blood vessels made from wire-like elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2002/018Filters implantable into blood vessels made from tubes or sheets of material, e.g. by etching or laser-cutting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/005Rosette-shaped, e.g. star-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0029Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in bending or flexure capacity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0039Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1093Balloon catheters with special features or adapted for special applications having particular tip characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool

Definitions

  • Implementations described herein relate generally to surgical devices and relate more specifically to percutaneous transluminal angioplasty devices.
  • the vascular bed supplies a constant flow of oxygen-rich blood to the organs.
  • Diseased vessels In diseased vessels, blockages can develop that can reduce blood flow to the organs and cause adverse clinical symptoms up to and including fatality.
  • Diseased vessels can comprise a range of material from early-stage thrombosis to late-stage calcified plaque.
  • Angioplasty can be described as a catheter-based procedure performed by a physician to open up a blocked vessel and restore blood flow.
  • An entry site can be opened, for example, in the patient's groin, arm, or hand, and a guide wire and catheter can be advanced under fluoroscopic guidance to the location of the blockage.
  • a catheter having a small balloon adjacent its distal end can be advanced under fluoroscopic guidance until the balloon lies within the stenosed region.
  • the balloon can be then inflated and deflated one or more times to expand the stenosed region of the artery.
  • Angioplasty can release embolic particles down-stream from the stenosed location. These embolic particles can result in adverse clinical consequences. It has been shown beneficial to trap these embolic particles to prevent them from traveling downstream with blood flow to the capillary bed (e.g., Baim D S, Wahr D, George B, et al, Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation 2002; 105: 1285-90).
  • stenoses can also be treated with stents and with mechanical atherectomy and thrombectomy devices. These devices can be also prone to releasing embolic particles downstream from the stenosed location.
  • a filter scaffolding configured to support a filter membrane is mounted at the distal end of the filter guidewire.
  • the filter scaffolding is movable between a retracted position, in which the scaffolding lies against the guidewire for insertion and retraction of the guidewire in the patient's body, and an expanded position in which the filter medium expands across substantially the entire vessel.
  • the prior art filter guidewire is inserted through the main lumen of the angioplasty catheter and advanced to a "landing zone" distal to the stenosis. The filter guidewire is then manipulated to deploy a filter scaffolding having a filter medium attached and configured to capture any emboli released by the angioplasty procedure.
  • This distance can be a problem not only in distal vein graft lesions, but also in arterial stenoses in which there can be a side branch immediately after the stenosis, such as native coronary arteries.
  • the filter can often be deployed only distal to the side branch, thus leaving the side branch unprotected from embolic particles.
  • the scaffolding further comprises a plurality of first longitudinal connecting members, each having a first end attached to the first ring and a second end extending toward the second ring; a plurality of second longitudinal connecting members, each having a first end attached to the second ring and a second end extending toward the first ring.
  • Each of the first and second longitudinal connecting members further comprise a bifurcation formed on the second end thereof, each of the bifurcations comprising first and second branches; and a means for connecting a branch on each of the plurality of first longitudinal connecting members to a branch on an opposite one of the plurality of second longitudinal connecting members.
  • the filter further comprises a membrane connected to at least the scaffolding.
  • FIG. 1 illustrates a side view of one aspect of an angioplasty device with integral embolic filter.
  • FIG. 2A illustrates a cross-section of the proximal end of the angioplasty device with integral embolic filter shown in FIG. 1 ; and FIG. 2B illustrates a cross-section of the distal end of the device shown in FIG. 1.
  • FIG. 4 illustrates a schematic view of the filter scaffolding of FIG. 3, showing the filter scaffolding in a deployed position.
  • FIG. 5 illustrates a schematic view of another aspect of a filter scaffolding of the angioplasty device of FIG. 1, showing the filter scaffolding in an un-deployed position.
  • FIG. 7 illustrates a schematic view of a third aspect of a filter scaffolding of the angioplasty device of FIG. 1, showing the filter scaffolding in an un-deployed position.
  • FIG. 8 illustrates a schematic view of the filter scaffolding of FIG. 7, showing the filter scaffolding in a deployed position.
  • FIG. 10 illustrates the blood vessel with stenosis of FIG. 9 with the angioplasty device of FIG. 1 positioned therein.
  • FIG. 1 1 illustrates the blood vessel and angioplasty device of FIG. 10 with the integral embolic filter expanded.
  • FIG. 12 illustrates the blood vessel and angioplasty device of FIG. 10 with the angioplasty balloon and integral embolic filter deployed.
  • FIG. 13 illustrates the blood vessel and angioplasty device of FIG. 10 after treatment of the stenosis, with the angioplasty balloon in its un-deployed position and the embolic filter still in its deployed position.
  • FIG. 14 illustrates the blood vessel and angioplasty device of FIG. 10 after treatment of the stenosis, with both the angioplasty balloon and embolic filter in an un- deployed position in preparation for withdrawal of the device from the vessel.
  • FIG. 15 illustrates an alternate aspect of a filter scaffolding comprising a sinusoidal frame.
  • FIG. 17 illustrates a side view of another aspect of an angioplasty device with integral embolic filter where the treatment device lies distal to the filter.
  • Angioplasty treatment devices comprise, for example and without limitation, inflatable balloons, expandable stents, atherectomy and thrombectomy devices and the like.
  • An embolic filter 30 can be mounted to the catheter shaft 14 at a location distal to the angioplasty treatment device 20 and at or proximal to the distal end 18 of the catheter 12. As illustrated in Figure 17, it is also contemplated that the embolic filter 30 can be mounted to the catheter shaft 14 at a location proximal to the treatment device 20. In additional or alternative embodiments, the filter 30 can be oriented to face towards or away from the treatment device.
  • the angioplasty catheter can be configured to be, for example and without limitation, an over-the-wire catheter, a rapid-exchange catheter and the like. It is solely for clarity of disclosure that the present description describes an over-the-wire catheter modality.
  • the catheter shaft 14 can define three lumens: a main lumen 32, an angioplasty balloon inflation lumen 34, and an embolic filter actuator wire lumen 36.
  • the main lumen 32 can extend from the proximal end 16 to the distal end 18 of the catheter shaft 14.
  • the main lumen 32 can optionally provide a working channel and be configured to receive a guidewire therethrough for advancing the distal end 18 of the catheter 12 through the patient's vasculature to a treatment site.
  • treatment site refers to the location of the occlusion within the patient's vasculature, and when the catheter 12 is referred to as being located or positioned at the treatment site, it will be understood to mean that the catheter is positioned such that the angioplasty treatment device 20 is located within the occlusion.
  • the balloon inflation lumen 34 can extend from a proximal port 38 at the proximal end 16 of the catheter 12 and through the catheter shaft 14 to a distal port 40 located within the angioplasty treatment device 20.
  • the actuator wire lumen 36 can extend from a proximal port 44 at the proximal end 16 of the catheter 12 and through the catheter shaft 14 to a distal port 46 distal to the angioplasty treatment device 20.
  • the embolic filter 30 comprises a filter membrane 50 (FIG. 12) having holes selectively sized to permit the passage of blood but to capture particles larger than normal blood particles and a collapsible scaffolding 52 for supporting the filter membrane.
  • the drawing figures omit the filter membrane 50 when illustrating the scaffolding 52, but it will be understood that all embolic filters disclosed in this application comprise a filter membrane supported by the scaffolding.
  • the scaffolding 52 can include a proximal ring 56 and a distal ring 54.
  • both of the rings can be located between the distal end of the angioplasty treatment device 20 and the distal end 18 of the catheter shaft.
  • the distal ring 54 can be fixed in place on the catheter shaft 14, and the proximal ring 56 can be slidably mounted to the catheter shaft for axial movement in the proximal and distal directions.
  • Each of a plurality of first strut sections 60 can have a first end 62 and a second end 64.
  • the first end 62 of each first strut section 60 can be attached to the distal ring 54, and each first strut section can extend in the proximal direction.
  • each of a corresponding plurality of second strut sections 70 can have a first end 72 and a second end 74.
  • the first end 72 of each second strut section 70 can be attached to the proximal ring 56, and each second strut section can also extend in the proximal direction.
  • the plurality of second strut sections 70 can be replaced with a sinusoidal ring structure 55 as illustrated in Figures 15-16.
  • the sinusoidal ring 55 contracts radially inward as the relative distance between the distal and proximal rings increases and expands as the relative distance between the distal and proximal rings decreases.
  • each first strut section 60 can attach to the second end 74 of a corresponding second strut section 70.
  • each connected first and second strut section 60, 70 collectively comprises a strut 80.
  • a plurality of strut 80 can be spaced circumferentially about and connecting the proximal and distal rings to form the scaffolding 52. In operation and as shown in FIG. 3, when the proximal and distal rings 56, 54 are adjacent one another each strut 80 can be configured to fold back upon itself.
  • the struts 80 can be configured to open in a manner similar to an umbrella.
  • the filter membrane 50 can be supported on the first strut sections 60 such that when the scaffolding 52 opens, as shown in FIG. 4, the filter membrane can deploy in a manner similar to an umbrella canopy.
  • each strut can further comprise at least one "zone of weakness," i.e., a zone of the strut that can be configured to be physically weaker than the majority of the strut in order to control the locations at which the struts bend.
  • the at least one zone of weakness can be formed in any of a number of ways. In one aspect, a notch can be formed in one or both sides of the strut. In another aspect, at least one of the upper surface and lower surface of the strut can be scored. In another aspect, the at least one zone of weakness can be formed of a material that can be structurally weaker than the material comprising the remainder of the strut.
  • the at least one zone of weakness can comprise mechanical hinges.
  • the apices of the sinusoidal ring 55 comprise a zone of weakness.
  • at least two of these approaches can be combined to form the at least one zone of weakness, e.g., both notching the width and scoring the depth of the strut.
  • the at least one zone of weakness can comprise a plurality of one type of physical arrangement, e.g., a single zone of weakness can comprise a plurality of notches or a plurality of scores.
  • the at least one zone of weakness can be configured to bend the strut in response to a force at a predetermined angle to the longitudinal axis of that portion of the strut.
  • movement of the proximal ring 56 toward and away from the distal ring 54 to open and to close the embolic filter 30 can be accomplished by manipulation of an actuator wire 84.
  • the proximal end 86 of the actuator wire 84 can extend out of the proximal port 44 of the actuator wire lumen 36 so as to be controllable by the physician performing the procedure.
  • the actuator wire 84 can extend through the actuator wire lumen 36 and can exit through the distal port 46 of the actuator wire lumen.
  • the distal end 88 of the actuator wire 84 can be attached to the proximal ring 56.
  • the filter scaffolding 52 and actuator wire 84 can be arranged to permit the embolic filter 30 to be opened and closed by moving the proximal end 86 of the actuator wire.
  • the filter scaffolding 52 can be formed in a normally closed or undeployed position. In operation, pulling the proximal end 86 of the actuator wire 84 can cause the proximal ring 56 to slide in a proximal direction to open the filter scaffolding 52.
  • the filter scaffolding can be configured so that releasing the tension on the actuator wire 84 and/or pushing the actuator wire 84 distally can permit the filter scaffolding 52 to collapse to an un-deployed position.
  • a filter scaffolding 152 can comprise a proximal ring 156 that can be fixed with respect to a catheter shaft 1 14 and a distal ring 154 that can be slidably positioned along the catheter shaft in the proximal and distal directions.
  • a distal port 146 of an actuator wire lumen 136 can be located distal to the proximal ring 156.
  • an actuator wire (not shown) can extend through the actuator wire lumen, can exit through a distal port 146, and can attach to the distal ring 154.
  • the filter scaffolding 152 can be formed in a normally closed position.
  • pushing the actuator wire 184 can displace the distal ring 154 in a distal direction away from the proximal ring 156 to deploy the filter scaffolding 152.
  • the filter scaffolding can be configured so that releasing the force on the actuator wire 184 and/or pushing the actuator wire 184 distally can permit the filter scaffolding 152 to return to its un- deployed position.
  • a proximal ring 254 can be fixed with respect to a catheter shaft 214, and a distal ring 256 can be slidably positioned along the catheter shaft in the proximal and distal directions.
  • a distal port 246 of an actuator wire lumen 236 can be located distal to the distal ring 256.
  • an actuator wire 284 can extend through the actuator wire lumen 236, can exit through the distal port 246, and can attach to the distal ring 256.
  • the filter scaffolding 252 can be formed in a normally closed position.
  • pulling on the actuator wire 284 can displace the distal ring 256 in a distal direction and away from the proximal ring 156 to deploy the filter scaffolding 252.
  • the filter scaffolding can be configured so that releasing the force on the actuator wire 284 can permit the filter scaffolding 252 to return to its un-deployed position.
  • FIGS. 3 and 4 another aspect of a filter scaffolding can be structurally identical to the first embodiment 52 except that the filter scaffolding can be formed in a normally open or deployed position.
  • application of a distally directed force to the proximal end 86 of the actuator wire 84 i.e., pushing the actuator wire
  • the filter scaffolding 52 can be permitted to expand to its normally deployed position, expanding the filter membrane 50, upon release of the force applied to the actuator wire 84.
  • a distally directed force can again be applied to the proximal end 86 of the actuator wire 84, moving the proximal ring 56 toward the distal ring 54 and collapsing the filter scaffolding 52.
  • a fifth aspect can be structurally identical to the third aspect with the exception that the filter scaffolding 152 can be formed in a normally open position.
  • the distal ring 154 can be normally displaced toward the distal end 18 of the catheter shaft 1 14.
  • pulling on the distal end 188 of the actuator wire 184 can move the distal ring 154 proximally toward the fixed proximal ring 156, collapsing the filter scaffolding 152 while releasing the tension on the actuator wire 184 can permit the filter scaffolding 152 to expand to its deployed position.
  • the force applied to the actuator wire is configured to be an axial compressive force
  • a stiffer wire can be used to prevent buckling of the actuator wire than in those embodiments where the force applied to the actuator wire is configured to be an axial tensile force.
  • wire is intended to comprise, for example and without limitation, metallic wires, polymeric wires, and the like.
  • polymeric wires the polymers used can comprise, for example and without limitation, nylon, polypropylene and the like.
  • the filter membrane 50 can be formed from at least one of a textile, a polymer and a wire mesh.
  • the filter membrane 50 comprises pores and, in a further aspect, the pores can be sized to allow blood to pass but not embolic particles. It is also contemplated that the filter membrane 50 can be mounted either on top of or inside of the frame.
  • the filter membrane 50 can be configured to cover the exterior surface of the outermost strut sections, i.e., the first strut sections 60, 160, and 260.
  • the filter membrane 50 can be further configured to extend beyond the distal or second ends 64, 164, and 264 of the first strut sections 60, 160, and 260, where it can be attached to the circumference of the distal ring 54, 156, 256.
  • the filter membrane 50 can optionally be configured to extend beyond the distal end of the distal ring and can be attached to the circumference of the catheter shaft 14 at a location between the distal ring 54 and the distal end 18 of the catheter shaft.
  • the filter membrane 50 in each of the disclosed embodiments can be attached to the inner surfaces of the first strut sections 60, 160, and 260 instead of to the outer surfaces.
  • the inner or second strut sections 70, 170, 270 can also be configured in a concave shape with respect to the blood flow when the filter scaffolding is deployed.
  • the filter membrane 50 can be attached to the inner or outer surfaces of the second strut sections 70, 170, 270.
  • the filter membrane 50 When the filter membrane 50 is attached to the surfaces of the second strut sections 70, 170, 270, the filter membrane 50 can optionally extend beyond the distal or second ends 74, 174, 274 of the second strut sections and be attached to the circumference of the proximal ring 56, 154, 254. It is also contemplated that, if the filter membrane 50 can be attached to the outer surfaces of the second strut sections 70 and the proximal ring 56 can be fixed, the filter membrane can be configured to extend beyond the distal end of the proximal ring and can be attached to the catheter shaft 14 at a location between the proximal and distal rings 56, 54.
  • the filter scaffolding comprises a fixed ring and a movable ring, raising the filter can be accomplished by moving the rings apart, and collapsing the filter can be achieved by moving the rings together.
  • "Moving apart” and “moving together” are used as relative terms, such that only one of the two rings need move with respect to the other ring for the rings to "move apart” or “move together.”
  • both actively applying a force to move a ring and releasing a force to permit the ring to move of its own accord comprise a step of "causing" the movable ring to move by "controlling" the actuator wire.
  • the actuator wire can be "controlled” to “cause” a movable ring to move, whether that control takes the form of applying or releasing a force on the actuator wire.
  • a control device can be associated with the proximal end of the actuator wire at the proximal end of the catheter shaft.
  • the control device can incorporate, for example and without limitation, levers, sliders, rotating spindles, or the like to facilitate movement of the wire.
  • levers, sliders, rotating spindles, or the like can be associated with the wire.
  • FIGS. 29-33 Use of the angioplasty device with integral embolic filter described above to treat a stenosis in a blood vessel can be shown in FIGS.
  • a vessel 500 can have a branch vessel 502 diverging from it.
  • the vessel 500 can have a stenosis 504.
  • the direction of blood flow through the vessel 500 is indicated by the arrow 506.
  • a guide wire 508 has been inserted by the physician as a preliminary step in the interventional procedure.
  • FIG. 10 shows the catheter 12 with angioplasty balloon 20 and embolic filter
  • the catheter 30 in their un-deployed positions and lying adjacent to the catheter shaft 14.
  • the distal end 18 of the catheter shaft 14 has been advanced over the guide wire 506 until the deflated angioplasty balloon 20 resides within the stenosis.
  • the catheter 12 With the catheter 12 positioned such that the angioplasty balloon 20 can be located within the stenosis, the catheter can be said to be at its "target site.” With the catheter at the target site, the portion of the vessel 500 occupied by the embolic filter 30 can be referred to as the "landing zone" 510.
  • the embolic filter 30 has been expanded by pulling on the actuator wire 84.
  • the angioplasty balloon 20 can be inflated and, if needed, deflated and re- inflated, optionally multiple times, to force the stenosis open.
  • embolic particles 510 are released and swept by the blood flow into the open proximal end of the embolic filter 30, where they are captured by the filter membrane 50.
  • the formerly stenosed region can be open, and the angioplasty balloon 20 has been deflated.
  • the embolic filter 30 remains open to capture any emboli released as the angioplasty balloon 20 deflates and pulls away from the wall of the vessel 500.
  • the embolic filter 30 can be closed, trapping captured emboli within the filter.
  • the catheter 12 can now be withdrawn from the vessel 500.
  • each of the disclosed embolic filters can be that, because the struts fold back on themselves, the filter scaffolding in its un-deployed position can be shorter than other known and/or commercially available embolic filters.
  • the shorter length can enable a shorter landing zone, which in turn can permit the filter to be placed closer to the angioplasty treatment means.
  • One result of providing a shorter landing zone can be a reduced likelihood that a branch blood vessel will intersect the stenosed blood vessel between the angioplasty treatment means and the embolic filter, thus reducing the chances of emboli bypassing the filter and getting caught up in the bloodstream.
  • the present disclosure permits the placement of the embolic filter very close to the means for treating the stenosis. This has the effect of minimizing the "landing area" of the filter and also permits the protection of side branches, as shown in FIGS. 22-25.

Abstract

A percutaneous transluminal angioplasty device includes an embolic filter mounted to the catheter shaft at a location distal to the angioplasty balloon. Thus the filter can be down-stream from the blockage and can be properly positioned to capture embolic particles that may be set loose into the blood stream as the angioplasty procedure can be performed. The embolic filter can be normally un-deployed against the catheter shaft to facilitate introduction and withdrawal of the device to and from the operative site. Once the angioplasty balloon can be properly positioned, however, means operatively associated with the embolic filter can be actuated to deploy the filter to position a filter mesh across the lumen of the vessel.

Description

PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY DEVICE
WITH INTEGRAL EMBOLIC FILTER
CROSS-REFERENCE TO RELATED APPLICATION
[0001] This application claims priority to U.S. Provisional Application No.
13/838,523, filed March 15, 2013, which is hereby incorporated by reference in its entirety.
BACKGROUND
Field of the Invention
[0002] Implementations described herein relate generally to surgical devices and relate more specifically to percutaneous transluminal angioplasty devices.
Related Art
[0003] The vascular bed supplies a constant flow of oxygen-rich blood to the organs.
In diseased vessels, blockages can develop that can reduce blood flow to the organs and cause adverse clinical symptoms up to and including fatality. Diseased vessels can comprise a range of material from early-stage thrombosis to late-stage calcified plaque.
[0004] Angioplasty can be described as a catheter-based procedure performed by a physician to open up a blocked vessel and restore blood flow. An entry site can be opened, for example, in the patient's groin, arm, or hand, and a guide wire and catheter can be advanced under fluoroscopic guidance to the location of the blockage. A catheter having a small balloon adjacent its distal end can be advanced under fluoroscopic guidance until the balloon lies within the stenosed region. The balloon can be then inflated and deflated one or more times to expand the stenosed region of the artery.
[0005] Angioplasty can release embolic particles down-stream from the stenosed location. These embolic particles can result in adverse clinical consequences. It has been shown beneficial to trap these embolic particles to prevent them from traveling downstream with blood flow to the capillary bed (e.g., Baim D S, Wahr D, George B, et al, Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation 2002; 105: 1285-90). [0006] In addition to balloon angioplasty, stenoses can also be treated with stents and with mechanical atherectomy and thrombectomy devices. These devices can be also prone to releasing embolic particles downstream from the stenosed location.
[0007] Systems available today used to catch these embolic particles consist primarily of filter systems or occlusion balloon systems, both built on a guidewire. Typically, a filter scaffolding configured to support a filter membrane is mounted at the distal end of the filter guidewire. The filter scaffolding is movable between a retracted position, in which the scaffolding lies against the guidewire for insertion and retraction of the guidewire in the patient's body, and an expanded position in which the filter medium expands across substantially the entire vessel. In use, the prior art filter guidewire is inserted through the main lumen of the angioplasty catheter and advanced to a "landing zone" distal to the stenosis. The filter guidewire is then manipulated to deploy a filter scaffolding having a filter medium attached and configured to capture any emboli released by the angioplasty procedure.
[0008] These systems suffer shortcomings related to simplicity of use and crossing tight lesions with a filter or balloon guidewire that can be larger in diameter than the guidewire which would normally be used. These embolic protection guidewires also suffer from flexibility and stability problems that render the protected angioplasty procedure relatively more difficult in many cases. In the case of saphenous vein grafts, the problems relate specifically to aorto-ostial lesions, where the guidewire may not be long enough to provide support, or distal vein graft lesions and renal artery lesions, where there can be not enough of a landing zone for the filter. The latter can be a problem as currently available filter systems can have a considerable distance between the treatment balloon and the distal filter. This distance can be a problem not only in distal vein graft lesions, but also in arterial stenoses in which there can be a side branch immediately after the stenosis, such as native coronary arteries. In such cases, the filter can often be deployed only distal to the side branch, thus leaving the side branch unprotected from embolic particles.
[0009] Accordingly, a need exists for improved percutaneous transluminal angioplasty devices having an integral embolic filter.
SUMMARY
[0010] It is to be understood that this summary is not an extensive overview of the disclosure. This summary is exemplary and not restrictive, and it is intended to neither identify key or critical elements of the disclosure nor delineate the scope thereof. The sole purpose of this summary is to explain and exemplify certain concepts of the disclosure as an introduction to the following complete and extensive detailed description.
[0011] Stated generally, the present disclosure comprises a percutaneous transluminal angioplasty device with integral embolic filter. Because the filter can be integral with the catheter of the angioplasty device, any need to insert a separate device into the vessel can be eliminated. Further, proper placement of the angioplasty balloon can assure proper placement of the embolic filter.
[0012] Stated more specifically, the present disclosure comprises a catheter having an elongated shaft, proximal and distal ends, a longitudinal axis and a filter. The filter comprises a first ring coaxially fixedly mounted on a distal portion of the catheter shaft, a second ring coaxially slidably mounted on a distal portion of the catheter shaft and configured to be moved toward and away from the first ring and a scaffolding extending between the first and second rings. The scaffolding further comprises a plurality of first longitudinal connecting members, each having a first end attached to the first ring and a second end extending toward the second ring; a plurality of second longitudinal connecting members, each having a first end attached to the second ring and a second end extending toward the first ring. Each of the first and second longitudinal connecting members further comprise a bifurcation formed on the second end thereof, each of the bifurcations comprising first and second branches; and a means for connecting a branch on each of the plurality of first longitudinal connecting members to a branch on an opposite one of the plurality of second longitudinal connecting members. The filter further comprises a membrane connected to at least the scaffolding.
[0013] Additional features and advantages of exemplary implementations of the disclosure will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of such exemplary implementations. The features and advantages of such implementations may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features will become more fully apparent from the following description and appended claims, or may be learned by the practice of such exemplary implementations as set forth hereinafter. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate aspects and together with the description, serve to explain the principles of the methods and systems.
[0015] FIG. 1 illustrates a side view of one aspect of an angioplasty device with integral embolic filter.
[0016] FIG. 2A illustrates a cross-section of the proximal end of the angioplasty device with integral embolic filter shown in FIG. 1 ; and FIG. 2B illustrates a cross-section of the distal end of the device shown in FIG. 1.
[0017] FIG. 3 illustrates a schematic view of one aspect of a filter scaffolding of the angioplasty device of FIG. 1, showing the filter scaffolding in an un-deployed position.
[0018] FIG. 4 illustrates a schematic view of the filter scaffolding of FIG. 3, showing the filter scaffolding in a deployed position.
[0019] FIG. 5 illustrates a schematic view of another aspect of a filter scaffolding of the angioplasty device of FIG. 1, showing the filter scaffolding in an un-deployed position.
[0020] FIG. 6 illustrates a schematic view of the filter scaffolding of FIG. 5, showing the filter scaffolding in a deployed position.
[0021] FIG. 7 illustrates a schematic view of a third aspect of a filter scaffolding of the angioplasty device of FIG. 1, showing the filter scaffolding in an un-deployed position.
[0022] FIG. 8 illustrates a schematic view of the filter scaffolding of FIG. 7, showing the filter scaffolding in a deployed position.
[0023] FIG. 9 illustrates a blood vessel having a stenosis.
[0024] FIG. 10 illustrates the blood vessel with stenosis of FIG. 9 with the angioplasty device of FIG. 1 positioned therein.
[0025] FIG. 1 1 illustrates the blood vessel and angioplasty device of FIG. 10 with the integral embolic filter expanded.
[0026] FIG. 12 illustrates the blood vessel and angioplasty device of FIG. 10 with the angioplasty balloon and integral embolic filter deployed.
[0027] FIG. 13 illustrates the blood vessel and angioplasty device of FIG. 10 after treatment of the stenosis, with the angioplasty balloon in its un-deployed position and the embolic filter still in its deployed position. [0028] FIG. 14 illustrates the blood vessel and angioplasty device of FIG. 10 after treatment of the stenosis, with both the angioplasty balloon and embolic filter in an un- deployed position in preparation for withdrawal of the device from the vessel.
[0029] FIG. 15 illustrates an alternate aspect of a filter scaffolding comprising a sinusoidal frame.
[0030] FIG. 16 illustrates one aspect of the attachment of the sinusoidal frame.
[0031] FIG. 17 illustrates a side view of another aspect of an angioplasty device with integral embolic filter where the treatment device lies distal to the filter.
DETAILED DESCRIPTION
[0032] The present invention can be understood more readily by reference to the following detailed description, examples, drawing, and claims, and their previous and following description. However, before the present devices, systems, and/or methods are disclosed and described, it is to be understood that this invention is not limited to the specific devices, systems, and/or methods disclosed unless otherwise specified, as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting.
[0033] The following description of the invention provided as an enabling teaching of the invention in its best, currently known aspect. To this end, those skilled in the relevant art will recognize and appreciate that many changes can be made to the various aspects of the invention described herein, while still obtaining the beneficial results described herein. It will also be apparent that some of the desired benefits described herein can be obtained by selecting some of the features described herein without utilizing other features. Accordingly, those who work in the art will recognize that many modifications and adaptations to the present invention are possible and can even be desirable in certain circumstances and are a part described herein. Thus, the following description is provided as illustrative of the principles described herein and not in limitation thereof.
[0034] Reference will be made to the drawings to describe various aspects of one or more implementations of the invention. It is to be understood that the drawings are diagrammatic and schematic representations of one or more implementations, and are not limiting of the present disclosure. Moreover, while various drawings are provided at a scale that is considered functional for one or more implementations, the drawings are not necessarily drawn to scale for all contemplated implementations. The drawings thus represent an exemplary scale, but no inference should be drawn from the drawings as to any required scale.
[0035] In the following description, numerous specific details are set forth in order to provide a thorough understanding described herein. It will be obvious, however, to one skilled in the art that the present disclosure may be practiced without these specific details. In other instances, well-known aspects of percutaneous transluminal angioplasty devices and embolic filters have not been described in particular detail in order to avoid unnecessarily obscuring aspects of the disclosed implementations.
[0036] As used in the specification and the appended claims, the singular forms "a," "an" and "the" include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from "about" one particular value, and/or to "about" another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent "about," it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
[0037] "Optional" or "optionally" means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.
[0038] Throughout the description and claims of this specification, the word "comprise" and variations of the word, such as "comprising" and "comprises," means "including but not limited to," and is not intended to exclude, for example, other additives, components, integers or steps. "Exemplary" means "an example of and is not intended to convey an indication of a preferred or ideal aspect. "Such as" is not used in a restrictive sense, but for explanatory purposes.
[0039] Referring now to the drawings, in which identical numbers indicate identical elements throughout the various views, FIG. 1 illustrates a first aspect of an angioplasty catheter with integral embolic filter 10 according to the present invention. The angioplasty catheter with integral embolic filter 10 comprises an elongated catheter 12 having a shaft 14 with a proximal end 16 and a distal end 18. As used herein, "proximal" refers to the portion of the device closest to the physician performing the procedure and "distal" refers to the portion of the device that is furthest from the physician performing the procedure. An angioplasty treatment device 20 can be mounted to the catheter 12 at a location near the distal end 18 of the catheter shaft 14. Angioplasty treatment devices comprise, for example and without limitation, inflatable balloons, expandable stents, atherectomy and thrombectomy devices and the like. An embolic filter 30 can be mounted to the catheter shaft 14 at a location distal to the angioplasty treatment device 20 and at or proximal to the distal end 18 of the catheter 12. As illustrated in Figure 17, it is also contemplated that the embolic filter 30 can be mounted to the catheter shaft 14 at a location proximal to the treatment device 20. In additional or alternative embodiments, the filter 30 can be oriented to face towards or away from the treatment device. One skilled in the art will also appreciate in light of the present disclosure that the angioplasty catheter can be configured to be, for example and without limitation, an over-the-wire catheter, a rapid-exchange catheter and the like. It is solely for clarity of disclosure that the present description describes an over-the-wire catheter modality.
[0040] Referring now to FIG. 2, the catheter shaft 14 can define three lumens: a main lumen 32, an angioplasty balloon inflation lumen 34, and an embolic filter actuator wire lumen 36. The main lumen 32 can extend from the proximal end 16 to the distal end 18 of the catheter shaft 14. The main lumen 32 can optionally provide a working channel and be configured to receive a guidewire therethrough for advancing the distal end 18 of the catheter 12 through the patient's vasculature to a treatment site. As used herein, the term "treatment site" refers to the location of the occlusion within the patient's vasculature, and when the catheter 12 is referred to as being located or positioned at the treatment site, it will be understood to mean that the catheter is positioned such that the angioplasty treatment device 20 is located within the occlusion.
[0041] The balloon inflation lumen 34 can extend from a proximal port 38 at the proximal end 16 of the catheter 12 and through the catheter shaft 14 to a distal port 40 located within the angioplasty treatment device 20. Similarly, the actuator wire lumen 36 can extend from a proximal port 44 at the proximal end 16 of the catheter 12 and through the catheter shaft 14 to a distal port 46 distal to the angioplasty treatment device 20.
[0042] Unless otherwise stated, all of the aspects disclosed below share the foregoing characteristics, and the various aspects differ primarily in the design of the embolic filter. Thus, as the various aspects are disclosed, it will be understood unless stated otherwise that each aspect includes the foregoing features, and the description will instead focus on the design and operation of the embolic filter. [0043] Referring to aspects of the present disclosure illustrated in FIGS. 3 and 4, the embolic filter 30 comprises a filter membrane 50 (FIG. 12) having holes selectively sized to permit the passage of blood but to capture particles larger than normal blood particles and a collapsible scaffolding 52 for supporting the filter membrane. For clarity of illustration, the drawing figures omit the filter membrane 50 when illustrating the scaffolding 52, but it will be understood that all embolic filters disclosed in this application comprise a filter membrane supported by the scaffolding. It is contemplated that the scaffolding 52 can include a proximal ring 56 and a distal ring 54. In one aspect, both of the rings can be located between the distal end of the angioplasty treatment device 20 and the distal end 18 of the catheter shaft. In a further aspect, the distal ring 54 can be fixed in place on the catheter shaft 14, and the proximal ring 56 can be slidably mounted to the catheter shaft for axial movement in the proximal and distal directions.
[0044] Each of a plurality of first strut sections 60 can have a first end 62 and a second end 64. The first end 62 of each first strut section 60 can be attached to the distal ring 54, and each first strut section can extend in the proximal direction.
[0045] In other aspects, each of a corresponding plurality of second strut sections 70 can have a first end 72 and a second end 74. Here, the first end 72 of each second strut section 70 can be attached to the proximal ring 56, and each second strut section can also extend in the proximal direction.
[0046] In yet other aspects, the plurality of second strut sections 70 can be replaced with a sinusoidal ring structure 55 as illustrated in Figures 15-16. In this aspect, the sinusoidal ring 55 contracts radially inward as the relative distance between the distal and proximal rings increases and expands as the relative distance between the distal and proximal rings decreases.
[0047] In yet other aspects, the second end 64 of each first strut section 60 can attach to the second end 74 of a corresponding second strut section 70. Here, each connected first and second strut section 60, 70 collectively comprises a strut 80. As one skilled in the art will appreciate from the discussion supra, a plurality of strut 80 can be spaced circumferentially about and connecting the proximal and distal rings to form the scaffolding 52. In operation and as shown in FIG. 3, when the proximal and distal rings 56, 54 are adjacent one another each strut 80 can be configured to fold back upon itself. Additionally, when the proximal ring 56 is proximally displaced from the distal ring 54, the struts 80 can be configured to open in a manner similar to an umbrella. The filter membrane 50 can be supported on the first strut sections 60 such that when the scaffolding 52 opens, as shown in FIG. 4, the filter membrane can deploy in a manner similar to an umbrella canopy.
[0048] It is contemplated that each strut can further comprise at least one "zone of weakness," i.e., a zone of the strut that can be configured to be physically weaker than the majority of the strut in order to control the locations at which the struts bend. One skilled in the art will appreciate that the at least one zone of weakness can be formed in any of a number of ways. In one aspect, a notch can be formed in one or both sides of the strut. In another aspect, at least one of the upper surface and lower surface of the strut can be scored. In another aspect, the at least one zone of weakness can be formed of a material that can be structurally weaker than the material comprising the remainder of the strut. In yet other aspects, the at least one zone of weakness can comprise mechanical hinges. In yet other aspects and as shown in Figure 15, the apices of the sinusoidal ring 55 comprise a zone of weakness. In even further aspects, at least two of these approaches can be combined to form the at least one zone of weakness, e.g., both notching the width and scoring the depth of the strut. In addition, the at least one zone of weakness can comprise a plurality of one type of physical arrangement, e.g., a single zone of weakness can comprise a plurality of notches or a plurality of scores. In operation, the at least one zone of weakness can be configured to bend the strut in response to a force at a predetermined angle to the longitudinal axis of that portion of the strut.
[0049] In operation, movement of the proximal ring 56 toward and away from the distal ring 54 to open and to close the embolic filter 30 can be accomplished by manipulation of an actuator wire 84. In one aspect, the proximal end 86 of the actuator wire 84 can extend out of the proximal port 44 of the actuator wire lumen 36 so as to be controllable by the physician performing the procedure. Here, the actuator wire 84 can extend through the actuator wire lumen 36 and can exit through the distal port 46 of the actuator wire lumen. In another aspect, the distal end 88 of the actuator wire 84 can be attached to the proximal ring 56.
[0050] One skilled in the art will appreciate here are a variety of ways in which the filter scaffolding 52 and actuator wire 84 can be arranged to permit the embolic filter 30 to be opened and closed by moving the proximal end 86 of the actuator wire. In a first aspect, the filter scaffolding 52 can be formed in a normally closed or undeployed position. In operation, pulling the proximal end 86 of the actuator wire 84 can cause the proximal ring 56 to slide in a proximal direction to open the filter scaffolding 52. The filter scaffolding can be configured so that releasing the tension on the actuator wire 84 and/or pushing the actuator wire 84 distally can permit the filter scaffolding 52 to collapse to an un-deployed position.
[0051] In another aspect of the present disclosure illustrated in FIGS. 5 and 6, a filter scaffolding 152 can comprise a proximal ring 156 that can be fixed with respect to a catheter shaft 1 14 and a distal ring 154 that can be slidably positioned along the catheter shaft in the proximal and distal directions. In a further aspect, a distal port 146 of an actuator wire lumen 136 can be located distal to the proximal ring 156. Here, an actuator wire (not shown) can extend through the actuator wire lumen, can exit through a distal port 146, and can attach to the distal ring 154. The filter scaffolding 152 can be formed in a normally closed position. In operation, pushing the actuator wire 184 can displace the distal ring 154 in a distal direction away from the proximal ring 156 to deploy the filter scaffolding 152. The filter scaffolding can be configured so that releasing the force on the actuator wire 184 and/or pushing the actuator wire 184 distally can permit the filter scaffolding 152 to return to its un- deployed position.
[0052] In yet another aspect of the present disclosure illustrated in FIGS. 7 and 8, a proximal ring 254 can be fixed with respect to a catheter shaft 214, and a distal ring 256 can be slidably positioned along the catheter shaft in the proximal and distal directions. In a further aspect, a distal port 246 of an actuator wire lumen 236 can be located distal to the distal ring 256. Here, an actuator wire 284 can extend through the actuator wire lumen 236, can exit through the distal port 246, and can attach to the distal ring 256. The filter scaffolding 252 can be formed in a normally closed position. In operation, pulling on the actuator wire 284 can displace the distal ring 256 in a distal direction and away from the proximal ring 156 to deploy the filter scaffolding 252. The filter scaffolding can be configured so that releasing the force on the actuator wire 284 can permit the filter scaffolding 252 to return to its un-deployed position.
[0053] Referring back to FIGS. 3 and 4, another aspect of a filter scaffolding can be structurally identical to the first embodiment 52 except that the filter scaffolding can be formed in a normally open or deployed position. Here, it is contemplated that application of a distally directed force to the proximal end 86 of the actuator wire 84 (i.e., pushing the actuator wire) can maintain the proximal ring 56 in its distal position and hence can maintain the filter scaffolding 52 in its un-deployed position. The filter scaffolding 52 can be permitted to expand to its normally deployed position, expanding the filter membrane 50, upon release of the force applied to the actuator wire 84. Immediately after completion of the interventional procedure, a distally directed force can again be applied to the proximal end 86 of the actuator wire 84, moving the proximal ring 56 toward the distal ring 54 and collapsing the filter scaffolding 52.
[0054] Referring back to FIGS. 5 and 6, a fifth aspect can be structurally identical to the third aspect with the exception that the filter scaffolding 152 can be formed in a normally open position. Here, it is contemplated that the distal ring 154 can be normally displaced toward the distal end 18 of the catheter shaft 1 14. In operation, pulling on the distal end 188 of the actuator wire 184 can move the distal ring 154 proximally toward the fixed proximal ring 156, collapsing the filter scaffolding 152 while releasing the tension on the actuator wire 184 can permit the filter scaffolding 152 to expand to its deployed position.
[0055] In those aspects in which the force applied to the actuator wire is configured to be an axial compressive force, those skilled in the art can appreciate that a stiffer wire can be used to prevent buckling of the actuator wire than in those embodiments where the force applied to the actuator wire is configured to be an axial tensile force.
[0056] In the present disclosure, and especially in the case of actuator wires, the term
"wire" is intended to comprise, for example and without limitation, metallic wires, polymeric wires, and the like. In the case of polymeric wires, the polymers used can comprise, for example and without limitation, nylon, polypropylene and the like.
[0057] In the foregoing aspects, the filter membrane 50 can be formed from at least one of a textile, a polymer and a wire mesh. In another aspect, the filter membrane 50 comprises pores and, in a further aspect, the pores can be sized to allow blood to pass but not embolic particles. It is also contemplated that the filter membrane 50 can be mounted either on top of or inside of the frame.
[0058] In the foregoing aspects, the filter membrane 50 can be configured to cover the exterior surface of the outermost strut sections, i.e., the first strut sections 60, 160, and 260. Optionally, the filter membrane 50 can be further configured to extend beyond the distal or second ends 64, 164, and 264 of the first strut sections 60, 160, and 260, where it can be attached to the circumference of the distal ring 54, 156, 256. In those aspects in which the distal ring 54 can be fixed, the filter membrane 50 can optionally be configured to extend beyond the distal end of the distal ring and can be attached to the circumference of the catheter shaft 14 at a location between the distal ring 54 and the distal end 18 of the catheter shaft.
[0059] It is also contemplated that the filter membrane 50 in each of the disclosed embodiments can be attached to the inner surfaces of the first strut sections 60, 160, and 260 instead of to the outer surfaces. [0060] It is further contemplated that the inner or second strut sections 70, 170, 270 can also be configured in a concave shape with respect to the blood flow when the filter scaffolding is deployed. In further or additional aspects, the filter membrane 50 can be attached to the inner or outer surfaces of the second strut sections 70, 170, 270. When the filter membrane 50 is attached to the surfaces of the second strut sections 70, 170, 270, the filter membrane 50 can optionally extend beyond the distal or second ends 74, 174, 274 of the second strut sections and be attached to the circumference of the proximal ring 56, 154, 254. It is also contemplated that, if the filter membrane 50 can be attached to the outer surfaces of the second strut sections 70 and the proximal ring 56 can be fixed, the filter membrane can be configured to extend beyond the distal end of the proximal ring and can be attached to the catheter shaft 14 at a location between the proximal and distal rings 56, 54.
[0061] In all of the foregoing instances, the filter scaffolding comprises a fixed ring and a movable ring, raising the filter can be accomplished by moving the rings apart, and collapsing the filter can be achieved by moving the rings together. "Moving apart" and "moving together" are used as relative terms, such that only one of the two rings need move with respect to the other ring for the rings to "move apart" or "move together."
[0062] Similarly, the process of raising and collapsing the filter can be thought of as being viewed from the perspective of the catheter, such that a movable ring can be moved toward or away from a fixed ring.
[0063] In all of the foregoing instances, one can appreciate that both actively applying a force to move a ring and releasing a force to permit the ring to move of its own accord comprise a step of "causing" the movable ring to move by "controlling" the actuator wire. Thus, in both the normally deployed and normally un-deployed filter scaffolding embodiments described herein, the actuator wire can be "controlled" to "cause" a movable ring to move, whether that control takes the form of applying or releasing a force on the actuator wire.
[0064] It is also contemplated that, rather than having the physician directly grasp the proximal end of the actuator wire, a control device can be associated with the proximal end of the actuator wire at the proximal end of the catheter shaft. The control device can incorporate, for example and without limitation, levers, sliders, rotating spindles, or the like to facilitate movement of the wire. One example of such a mechanical arrangement is described in U.S. Patent Publication No. US 2010/0106182, paragraphs [0079]-[0090] and FIGS. 29-33, which disclosure is hereby incorporated by reference. [0065] Use of the angioplasty device with integral embolic filter described above to treat a stenosis in a blood vessel can be shown in FIGS. 9-13. In FIG. 9, a vessel 500 can have a branch vessel 502 diverging from it. The vessel 500 can have a stenosis 504. The direction of blood flow through the vessel 500 is indicated by the arrow 506. A guide wire 508 has been inserted by the physician as a preliminary step in the interventional procedure.
[0066] FIG. 10 shows the catheter 12 with angioplasty balloon 20 and embolic filter
30 in their un-deployed positions and lying adjacent to the catheter shaft 14. The distal end 18 of the catheter shaft 14 has been advanced over the guide wire 506 until the deflated angioplasty balloon 20 resides within the stenosis. With the catheter 12 positioned such that the angioplasty balloon 20 can be located within the stenosis, the catheter can be said to be at its "target site." With the catheter at the target site, the portion of the vessel 500 occupied by the embolic filter 30 can be referred to as the "landing zone" 510.
[0067] In FIG. 11 the embolic filter 30 has been expanded by pulling on the actuator wire 84. In FIG. 12 the angioplasty balloon 20 can be inflated and, if needed, deflated and re- inflated, optionally multiple times, to force the stenosis open. In the process of crushing the plaque that forms the stenosis, embolic particles 510 are released and swept by the blood flow into the open proximal end of the embolic filter 30, where they are captured by the filter membrane 50.
[0068] In FIG. 13, the formerly stenosed region can be open, and the angioplasty balloon 20 has been deflated. The embolic filter 30 remains open to capture any emboli released as the angioplasty balloon 20 deflates and pulls away from the wall of the vessel 500.
[0069] In FIG. 14, the embolic filter 30 can be closed, trapping captured emboli within the filter. The catheter 12 can now be withdrawn from the vessel 500.
[0070] One aspect of each of the disclosed embolic filters can be that, because the struts fold back on themselves, the filter scaffolding in its un-deployed position can be shorter than other known and/or commercially available embolic filters. The shorter length can enable a shorter landing zone, which in turn can permit the filter to be placed closer to the angioplasty treatment means. One result of providing a shorter landing zone can be a reduced likelihood that a branch blood vessel will intersect the stenosed blood vessel between the angioplasty treatment means and the embolic filter, thus reducing the chances of emboli bypassing the filter and getting caught up in the bloodstream.
[0071] Thus, implementations of the foregoing provide various desirable features.
For instance, the present disclosure permits the placement of the embolic filter very close to the means for treating the stenosis. This has the effect of minimizing the "landing area" of the filter and also permits the protection of side branches, as shown in FIGS. 22-25.
[0072] The present invention can thus be embodied in other specific forms without departing from its spirit or essential characteristics. The described aspects are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims

1. An apparatus comprising: a catheter having an elongated shaft, proximal and distal ends, and a longitudinal axis; and a filter membrane support structure, comprising: a first ring coaxially fixedly mounted on a distal portion of said catheter shaft; a second ring coaxially slideably mounted on a distal portion of said catheter shaft for movement toward and away from said first ring; and a scaffolding extending between said first and second rings, the scaffolding being movable between collapsed and expanded configurations, said scaffolding comprising: first longitudinal connecting members having a first end attached to said first ring and a second end extending toward said second ring; a sinusoidal ring structure having radius, a first set of apices, and a second set of apices, wherein the first set of apices are attached to the second ring and the second set of apices are attached to the second end of the first longitudinal connecting members.
2. The apparatus of Claim 1, wherein the catheter further comprises a lumen formed therein, the lumen extending from a first opening formed in the catheter at or proximate the proximal end of the catheter to a second opening formed in the catheter proximate the distal end of the catheter.
3. The apparatus of Claim 2, further comprising an actuator wire extending through the lumen of the catheter, the actuator wire having a proximal end extending through the first opening of the lumen and a distal end extending through a second opening in the lumen and operatively associated with the second ring.
4. The apparatus of Claim 3, wherein the scaffolding is normally collapsed against the shaft of the catheter.
5. The apparatus of Claim 4, wherein application of a tension to the actuator wire draws the slidable second ring towards the first ring to expand the scaffolding.
6. The apparatus of Claim 5, wherein removing the tension from the actuator wire permits the scaffolding to collapse back against the shaft of the catheter.
7. The apparatus of Claim 1 , further comprising a treatment device mounted to the shaft of the catheter.
8. The apparatus of Claim 7, wherein the treatment device can be located proximal to the filter membrane support structure.
9. The apparatus of Claim 7, wherein the treatment device can be located distal to the filter membrane support structure.
10. The apparatus of Claim 7, wherein the treatment device can comprise at least one of an inflatable balloon, an expandable stent, an atherectomy device, and a thrombectomy device.
11. The apparatus of Claim 1, further comprising points of weakness formed on the support frame to facilitate controlled bending.
12. The apparatus of Claim 1 1, wherein the points of weakness comprise the second set of apices of the sinusoidal ring structure.
13. The apparatus of Claim 1, further comprising a filter membrane.
14. The apparatus of Claim 13, wherein the filter membrane overlies at least a portion of the filter membrane support structure.
15. The apparatus of Claim 1, wherein the radius of the sinusoidal ring structure is adapted to decrease as the relative distance between the first and second ring increases.
16. The apparatus of Claim 1, wherein the radius of the sinusoidal ring structure is adapted to increase as the relative distance between the first and second ring decreases.
PCT/US2014/021850 2013-03-15 2014-03-07 Percutaneous transluminal angioplasty device with integral embolic filter WO2014150013A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2016500864A JP2016511086A (en) 2013-03-15 2014-03-07 Percutaneous angioplasty device with integrated embolic filter
CN201480025256.6A CN105188605B (en) 2013-03-15 2014-03-07 Percutaneous transluminal angio plasty device with integrated embolism filter
BR112015023627A BR112015023627A8 (en) 2013-03-15 2014-03-07 percutaneous transluminal device
EP14768559.8A EP2967808A4 (en) 2013-03-15 2014-03-07 Percutaneous transluminal angioplasty device with integral embolic filter
AU2014237626A AU2014237626A1 (en) 2013-03-15 2014-03-07 Percutaneous transluminal angioplasty device with integral embolic filter
HK16102513.6A HK1214495A1 (en) 2013-03-15 2016-03-04 Percutaneous transluminal angioplasty device with integral embolic filter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/838,523 2013-03-15
US13/838,523 US20170007390A9 (en) 2004-11-24 2013-03-15 Percutaneous transluminal angioplasty device with integral embolic filter

Publications (1)

Publication Number Publication Date
WO2014150013A1 true WO2014150013A1 (en) 2014-09-25

Family

ID=51580687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/021850 WO2014150013A1 (en) 2013-03-15 2014-03-07 Percutaneous transluminal angioplasty device with integral embolic filter

Country Status (7)

Country Link
EP (1) EP2967808A4 (en)
JP (1) JP2016511086A (en)
CN (1) CN105188605B (en)
AU (1) AU2014237626A1 (en)
BR (1) BR112015023627A8 (en)
HK (1) HK1214495A1 (en)
WO (1) WO2014150013A1 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015070147A1 (en) * 2013-11-08 2015-05-14 Contego Medical, Llc Percutaneous catheter-based arterial denervation with integral embolic filter
WO2016112032A1 (en) * 2015-01-05 2016-07-14 Boston Scientific Scimed, Inc. Flexible member for resisting retrograde flow
US9510930B2 (en) 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
US9707071B2 (en) 2004-11-24 2017-07-18 Contego Medical Llc Percutaneous transluminal angioplasty device with integral embolic filter
CN108366853A (en) * 2015-10-09 2018-08-03 特伦沃斯医疗有限公司 Device and method catheter-based
US10292805B2 (en) 2015-01-23 2019-05-21 Contego Medical, Llc Interventional device having an integrated embolic filter and associated methods
US10743907B2 (en) 2014-11-07 2020-08-18 National University Of Ireland, Galway Thrombectomy device
US10779852B2 (en) 2013-03-15 2020-09-22 National University Of Ireland, Galway Device suitable for removing matter from inside the lumen and the wall of a body lumen
CN115844491A (en) * 2022-12-06 2023-03-28 杭州亿科医疗科技有限公司 Get controllable device of getting of bolt net shrink expansion

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974349B (en) * 2019-11-25 2022-08-02 湖南瑞康通科技发展有限公司 Bolt taking device and bolt taking assembly
CN112245750B (en) * 2020-09-24 2023-08-15 中国人民解放军陆军军医大学第二附属医院 Multifunctional trachea cannula

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094249B1 (en) * 1997-03-06 2006-08-22 Boston Scientific Scimed, Inc. Distal protection device and method
WO2009151761A1 (en) * 2008-04-10 2009-12-17 Contego Medical Llc Angioplasty device with embolic filter and fixed filter housing
US7935075B2 (en) * 2005-04-26 2011-05-03 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814064A (en) * 1997-03-06 1998-09-29 Scimed Life Systems, Inc. Distal protection device
US6562058B2 (en) * 2001-03-02 2003-05-13 Jacques Seguin Intravascular filter system
US6635070B2 (en) * 2001-05-21 2003-10-21 Bacchus Vascular, Inc. Apparatus and methods for capturing particulate material within blood vessels
US20030060843A1 (en) * 2001-09-27 2003-03-27 Don Boucher Vascular filter system with encapsulated filter
US6890340B2 (en) * 2001-11-29 2005-05-10 Medtronic Vascular, Inc. Apparatus for temporary intraluminal protection
US7001406B2 (en) * 2002-05-23 2006-02-21 Scimed Life Systems Inc. Cartridge embolic protection filter and methods of use
US20060100658A1 (en) * 2004-11-09 2006-05-11 Hiroyuki Obana Interventional guiding sheath system and method of use
US9510930B2 (en) * 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
US9707071B2 (en) * 2004-11-24 2017-07-18 Contego Medical Llc Percutaneous transluminal angioplasty device with integral embolic filter
JP2009517124A (en) * 2005-11-26 2009-04-30 コンテゴ メディカル エルエルシー Percutaneous transluminal angioplasty device with integrated embolic filter

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094249B1 (en) * 1997-03-06 2006-08-22 Boston Scientific Scimed, Inc. Distal protection device and method
US7935075B2 (en) * 2005-04-26 2011-05-03 Cardiac Pacemakers, Inc. Self-deploying vascular occlusion device
WO2009151761A1 (en) * 2008-04-10 2009-12-17 Contego Medical Llc Angioplasty device with embolic filter and fixed filter housing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2967808A4 *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9707071B2 (en) 2004-11-24 2017-07-18 Contego Medical Llc Percutaneous transluminal angioplasty device with integral embolic filter
US10702367B2 (en) 2004-11-24 2020-07-07 Contego Medical, Llc Percutaneous transluminal angioplasty device with integral embolic filter
US9510930B2 (en) 2008-10-22 2016-12-06 Contego Medical, Llc Angioplasty device with embolic filter
US11406418B2 (en) 2013-03-15 2022-08-09 Vetex Medial Limited Thrombectomy devices with control assemblies
US11896257B2 (en) 2013-03-15 2024-02-13 Vetex Medical Limited Thrombectomy devices with control assemblies
US11317939B2 (en) 2013-03-15 2022-05-03 Vetex Medical Limited Thrombectomy devices with maceration
US10779852B2 (en) 2013-03-15 2020-09-22 National University Of Ireland, Galway Device suitable for removing matter from inside the lumen and the wall of a body lumen
US10813663B2 (en) 2013-03-15 2020-10-27 National University Of Ireland, Galway Device suitable for removing matter from inside the lumen and the wall of a body lumen
US10874421B2 (en) 2013-03-15 2020-12-29 National University Of Ireland, Galway Extraction devices
US11278307B2 (en) 2013-03-15 2022-03-22 Vetex Medical Limited Thrombectomy devices with aspiration
WO2015070147A1 (en) * 2013-11-08 2015-05-14 Contego Medical, Llc Percutaneous catheter-based arterial denervation with integral embolic filter
US10743907B2 (en) 2014-11-07 2020-08-18 National University Of Ireland, Galway Thrombectomy device
US10238791B2 (en) 2015-01-05 2019-03-26 Boston Scientific Scimed, Inc. Flexible member for resisting retrograde flow
WO2016112032A1 (en) * 2015-01-05 2016-07-14 Boston Scientific Scimed, Inc. Flexible member for resisting retrograde flow
US11166802B2 (en) 2015-01-23 2021-11-09 Contego Medical, Inc. Interventional device having an integrated embolic filter and associated methods
US10292805B2 (en) 2015-01-23 2019-05-21 Contego Medical, Llc Interventional device having an integrated embolic filter and associated methods
US11844679B2 (en) 2015-01-23 2023-12-19 Contego Medical, Llc Interventional device having an integrated embolic filter and associated methods
CN108366853A (en) * 2015-10-09 2018-08-03 特伦沃斯医疗有限公司 Device and method catheter-based
CN115844491A (en) * 2022-12-06 2023-03-28 杭州亿科医疗科技有限公司 Get controllable device of getting of bolt net shrink expansion

Also Published As

Publication number Publication date
BR112015023627A8 (en) 2019-12-03
AU2014237626A2 (en) 2017-06-15
AU2014237626A1 (en) 2015-10-01
HK1214495A1 (en) 2016-07-29
BR112015023627A2 (en) 2017-07-18
JP2016511086A (en) 2016-04-14
EP2967808A4 (en) 2017-01-25
EP2967808A1 (en) 2016-01-20
CN105188605A (en) 2015-12-23
CN105188605B (en) 2018-02-02

Similar Documents

Publication Publication Date Title
US11865022B2 (en) Transluminal angioplasty devices and methods of use
US20160287844A1 (en) Percutaneous transluminal angioplasty device with integral embolic filter
US8758424B2 (en) Percutaneous transluminal angioplasty device with integral embolic filter
WO2014150013A1 (en) Percutaneous transluminal angioplasty device with integral embolic filter
US10702367B2 (en) Percutaneous transluminal angioplasty device with integral embolic filter
EP2925257B1 (en) Percutaneous transluminal angioplasty device with integral embolic filter
US20140214067A1 (en) Percutaneous transluminal angioplasty device with integral embolic filter
US6547759B1 (en) Emboli capturing device
US9895216B2 (en) Percutaneous emboli protection sleeve
US11844679B2 (en) Interventional device having an integrated embolic filter and associated methods
US20100106182A1 (en) Angioplasty device with embolic filter
US20160089228A1 (en) Temporary embolic protection device and methods thereof
JP2009517124A (en) Percutaneous transluminal angioplasty device with integrated embolic filter
US20070073332A1 (en) Intraluminal filter having a cover sleeve
JP2013154183A (en) Percutaneous intravascular blood vessel formation device having integrated embolic filter
WO2009151761A1 (en) Angioplasty device with embolic filter and fixed filter housing
EP4212127A1 (en) System for protecting the cerebral vasculature
WO2002083225A1 (en) Emboli capturing device

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201480025256.6

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14768559

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016500864

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2014768559

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2014237626

Country of ref document: AU

Date of ref document: 20140307

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112015023627

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112015023627

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20150915